In: PATENT NEWS
Requires Bachelor’s degree in Engineering or Science and a minimum of two years of experience drafting, filing and prosecuting patent applications in the USPTO for an intellectual property law firm. Must be registered to practice before the U.S. Patent and Trademark Office (PTO). Must have excellent …
In: PATENT NEWS
[B]ecause patent agents are authorized to practice law before the USPTO, they fall within [Texas Rules of Evidence] Rule 503’s definition of “lawyer,” and, … In the case, the trial court had concluded that a party’s communications with a patent agent were only privileged to the extent that the patent... Continue reading
In: PATENT NEWS
Law360 (February 23, 2018, 11:28 AM EST) — After a three-year surge, patent suits at the Federal Circuit leveled off last year as the court showed signs of adjusting to its bustling workload. The judges found time to write more opinions, and they reached greater consensus, penning fewer separate …
In: PATENT NEWS
Law360 (February 23, 2018, 11:29 AM EST) — The Texas Supreme Court on Friday sided with an inventor and upended a trial court’s order that he turn over more than 300 emails between himself and his nonattorney patent agent in a dispute over restaurant technology, holding that the communications …
In: TRADEMARK NEWS
“We’re running out of good trademarks” – groundbreaking study reveals 81% of common words are registered marks World Trademark Review (blog) Full coverage
In: PATENT NEWS
Designing aftermarket auto parts: exhausting design patent rights The National Law Review Full coverage
In: TRADEMARK NEWS
Overview of the Myanmar Trademark Bill 2017 Lexology Full coverage
In: PATENT NEWS
Patent Eligibility: Handling Disputed Issues of Material Fact Patently-O Full coverage
In: PATENT NEWS
Appeals court rejects bid by Google to escape digital ad patent case Reuters Full coverage
In: PATENT NEWS
Law360 (February 22, 2018, 7:26 PM EST) — The Patent Trial and Appeal Board on Wednesday upheld the validity of a patent covering Biogen Inc. and … 7,820,161 B1 was doomed by Celltrion and Pfizer’s inability to prove one of the main pieces of prior art they relied on was... Continue reading
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION